pac.dog pac.dog / Lobbying

1st Quarter - Report · 2025

Filing UUID
769fe845-fb48-40aa-aa98-725448408b14
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2025
Posted
2025-04-02 15:32:24
Income (reported)
$20,000
Expenses (reported)
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

BUCHANAN INGERSOLL & ROONEY PC

law firm

Contact
WILL LE
Phone
+1 202-452-5783
Address
zip:20006, city:Washington, state:DC, street:1700 K Street, NW Suite 300

Client

AIM IMMUNOTECH INC.

Biopharmaceutical company

State
FL
Country
US
Government-entity client
false
Effective date
2020-05-22

Issues lobbied + lobbyists

HCR — Health Issues

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. Work with Department of Defense on Ebola countermeasures. Comprehensive Access to Resources and Education (CARE) For Long COVID Act

Lobbyists: mr JAMES C WILTRAUT jr; EDWARD HILD (covered position: Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici); SOPHIA ESTUPINAN

Government entities lobbied: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE

PHA — Pharmacy

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. Work with Department of Defense on Ebola countermeasures. Comprehensive Access to Resources and Education (CARE) For Long COVID Act

Lobbyists: mr JAMES C WILTRAUT jr; EDWARD HILD (covered position: Chief of Staff, Sen. Lisa Murkowski; Deputy Chief of Staff, Sen. Pete Domenici); SOPHIA ESTUPINAN

Government entities lobbied: Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.